I am pleased we are holding this oversight hearing on the legislation that we passed last year on a bipartisan basis.
Editor's note · Context
Waxman expresses satisfaction with the bipartisan oversight hearing on FDA legislation.
Share
More from Henry Waxman
So what we are seeing is something that sounds good from a party that has no credibility to say that they are for more science information. What they would do is limit what EPA would be able to use to determine, based on the science, what…
Mr. Chairman, too much dirty politics is waged with dark money, the secrecy is protected by no privilege, and a little sunlight would be very healthy for American democracy.
I hope this committee will initiate a detailed investigation examining this network of front groups and trade associations, determine who funds them and expose how they coordinate with industry.
I claim the time in opposition, although I am not opposed to the amendment. The CHAIR. Without objection, the gentleman from California is recognized for 5 minutes. There was no objection.





